Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ABCL

AbCellera Biologics (ABCL)

AbCellera Biologics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABCL
DateTimeSourceHeadlineSymbolCompany
11/03/202508:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
08/03/202507:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
28/02/202509:12Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ABCLAbCellera Biologics Inc
28/02/202508:36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ABCLAbCellera Biologics Inc
28/02/202508:24Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ABCLAbCellera Biologics Inc
28/02/202508:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
28/02/202508:05Business WireAbCellera Reports Full Year 2024 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
19/02/202503:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
12/02/202508:05Business WireAbCellera to Participate at Upcoming Investor Conferences in MarchNASDAQ:ABCLAbCellera Biologics Inc
22/01/202508:05Business WireAbCellera to Report Full Year 2024 Financial Results on February 27, 2025NASDAQ:ABCLAbCellera Biologics Inc
14/01/202501:00Business WireAbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for OncologyNASDAQ:ABCLAbCellera Biologics Inc
04/01/202507:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
04/01/202507:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
04/01/202507:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
04/01/202507:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
06/12/202408:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
27/11/202409:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
22/11/202408:05Business WireAbCellera to Present at Upcoming Investor Conferences in December and JanuaryNASDAQ:ABCLAbCellera Biologics Inc
08/11/202402:05Business WireAbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024NASDAQ:ABCLAbCellera Biologics Inc
05/11/202408:34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABCLAbCellera Biologics Inc
05/11/202408:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
05/11/202408:05Business WireAbCellera Reports Q3 2024 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
23/10/202407:05Business WireAbCellera to Present at Upcoming Investor Conferences in November 2024NASDAQ:ABCLAbCellera Biologics Inc
04/10/202423:00Business WireAbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024NASDAQ:ABCLAbCellera Biologics Inc
27/09/202406:05Business WireAbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024NASDAQ:ABCLAbCellera Biologics Inc
25/09/202406:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
30/08/202406:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
30/08/202406:05Business WireAbCellera to Present at Upcoming Investor Conferences in SeptemberNASDAQ:ABCLAbCellera Biologics Inc
07/08/202406:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABCLAbCellera Biologics Inc
07/08/202406:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:ABCL